Currently out of the existing stock ratings of Matthew Gillmor, 23 are a HOLD (16.55%), 116 are a BUY (83.45%).

Matthew Gillmor

Work Performance Price Targets & Ratings Chart

Analyst Matthew Gillmor, currently employed at KEYBANK, carries an average stock price target met ratio of 72.62% that have a potential upside of 19.36% achieved within 207 days.

Matthew Gillmor’s has documented 283 price targets and ratings displayed on 31 stocks. The coverage is on Healthcare, Technology, Consumer Cyclical sectors.

Most recent stock forecast was given on HCA, HCA Holdings at 26-Jul-2026.

Wall Street Analyst Matthew Gillmor

Analyst best performing recommendations are on TDOC (TELADOC).
The best stock recommendation documented was for TDOC (TELADOC) at 2/27/2020. The price target of $130 was fulfilled within 1 day with a profit of $5.15 (3.81%) receiving and performance score of 38.11.

Average potential price target upside

of $76.15 (26.33%) on UNH (UNITEDHEALTH GROUP).
of $47.91 (22.39%) on HCA (HCA HOLDINGS).
of $16.47 (17.4%) on TDOC (TELADOC).

ACCD Accolade ADUS Addus HomeCare EVH Evolent Health TDOC Teladoc TRHC Tabula Rasa HealthCare VCRA Vocera Communications CERN Cerner Corp ATHN athenahealth HSTM HealthStream RCM R1 RCM ACHC Acadia Healthcare Company EHC Encompass Health Corp HCA HCA Holdings THC Tenet Healthcare UHS Universal Health Services ALHC Alignment Healthcare LLC AMED Amedisys CHNG Change Healthcare DVA DaVita HealthCare Partners HMSY HMS Holdings Corp MD Mednax MDRX Allscripts Healthcare Solutions OSH Oak Street Health UNH UnitedHealth Group INNV InnovAge Holding Corp PHR Phreesia SGRY Surgery Partners ARDT Ardent Health Partners INOV Inovalon Holdings OS OneStream, Common Stock VC Visteon Corp

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Jeff Garro (STEPHENS)